Stockreport

Eli Lilly EBGLYSS Data Highlights Long Term AD Potential Beyond Obesity [Yahoo! Finance]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF Eli Lilly (NYSE:LLY) presented new four year data on EBGLYSS for moderate to severe atopic dermatitis at the AAD Annual Meeting. The open label extension study report [Read more]